PATENT CLAIM ANALYSIS

Application Number: 16046382
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["514", "210000"]

Abstract:
This invention relates to generally inhibiting histone deacetylase (“HDAC”) enzymes (e.g., HDAC1, HDAC2, and HDAC3).

Claim (Index 1):
A compound selected from the group consisting of: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 95.0
- Lexical Diversity: 1.19048
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16046304', '14598583', '15337354', '13823708', '13843261']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8016776274328783
- 35 USC 102 Novelty (BERT): 0.5097832756742307
- Combined Prediction Score: 0.7724881922570135
- Mean Citation Score: 294.157698
- Max Citation Score: 297.36005
- Similarity Product: 272.86670264270305

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test